Centrifugal Flow Fractionation for Lipid Nanoparticle Size-Density Profiling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing nanoparticles in nanomedicine, such as electron microscopy and dynamic light scattering, do not adequately consider particle size and density for evaluating physicochemical properties, limiting the sophisticated evaluation of nanoparticle qualities.
Innovation Solution
A method using centrifugal field flow fractionation (CF3) is employed to detect, profile, sort, and isolate nanoparticles based on size and density, utilizing a carrier solution with monosaccharides like glucose, and detectors like MALS and photodiode array detectors to identify and separate lipid nanoparticles encapsulating therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If electron microscopy and dynamic light scattering are used to characterize nanoparticles, then particle size can be determined, but particle density and comprehensive physicochemical properties cannot be adequately evaluated
Solution Approach 1:
The patent combines centrifugal field flow fractionation with multi-angle light scattering detection to simultaneously measure both particle size and particle density. This merging of separation technique with comprehensive detection resolves the limitation of using single-method characterization that could only measure size but not density or other physicochemical properties.
Solution Approach 2:
The centrifugal field flow fractionation system is designed to perform multiple functions: it separates particles by size and density simultaneously, and the multi-angle light scattering detector provides comprehensive physicochemical characterization including size, density, and other properties. This multi-functional approach eliminates the need for multiple separate measurement techniques.
2Measurement precision
If centrifugal field flow fractionation is used to separate particles by size and density, then comprehensive particle characterization is achieved, but the complexity of the system increases
Solution Approach 1:
The system segments the characterization process into distinct functional modules: the centrifugal field flow fractionation unit for separation, the multi-angle light scattering detector for optical measurement, and data processing units for analysis. This segmentation allows each component to be optimized independently while working together to provide comprehensive particle characterization.
Solution Approach 2:
The patent uses a carrier solution with specific physical properties as an intermediary medium that enables the centrifugal field flow fractionation process. This intermediary allows particles to be separated and characterized without requiring direct interaction between the measurement devices and the nanoparticle sample, simplifying the overall system architecture.
3Reliability
If nanoparticles are sorted and isolated by size and density, then therapeutic efficacy can be enhanced, but the time required for characterization and isolation increases
Solution Approach 1:
The system performs preliminary separation and characterization of nanoparticles before therapeutic application. By pre-sorting particles by size and density and identifying those with optimal properties, the process ensures therapeutic efficacy is maximized while the time investment is justified by the improved outcome. The multi-angle light scattering detection provides rapid comprehensive characterization to guide the selection process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate sorting and isolation of nanoparticles by size and density, facilitating the preparation of pharmaceutical compositions with therapeutic agents like mRNA vaccines, cancer drugs, or RNAi drugs, enhancing the evaluation of nanoparticle qualities and therapeutic efficacy.
Implementation Method 1
centrifugal field flow fractionation (CF3)... separate particles based on their sizes as well as the difference in density between the particles and the elution fluid
Implementation Method 2
detecting... performed using at least one selected from the group consisting of a multi-angle light scattering (MALS) detector
Data Source
AI summary
The present disclosure provides a method of detecting size, density, or size and density of the lipid nanoparticles. The detection may be performed by centrifugal field flow fractionation using a carrier solution comprising a monosaccharide.